New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
22nd March 2023
21st March 2023
Canada: Health Canada has updated the fees laid out in the Cannabis Fees Order, following the 2022 Consumer Price Index of 6.8%. The new rates will apply from 1st April.
21st March 2023
US - Kentucky: House Bill 544 has been delivered to the governor for approval after being passed by the Senate. It would set guidelines for the regulation of hemp-derived delta-8 THC products, including banning their sale of delta-8 to under-21s. It also set new retail, labelling and testing requirements, and would direct the state Cabinet for Health and Family Services to establish administrative regulations for the production and sale of delta-8 products by 1st August.
21st March 2023
US - Oklahoma: House Bill 2095 has passed the House and now heads to the Senate. It would broaden the remit of the Oklahoma Medical Marijuana Authority and other state agencies through monetary and disciplinary provisions, such as authorising unannounced site inspections. The bill also lays down penalties for unlawful acts, such as the permanent revocation of medical cannabis business licences for non-payment of taxes.
20th March 2023
20th March 2023
20th March 2023
17th March 2023
17th March 2023
17th March 2023
17th March 2023
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.